Last updated on November 2018

An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice


Brief description of study

This study, a national, multicenter, observational, ambispective, non-interventional study, will be conducted in French hospitals prescribing pomalidomide and already participating in the ongoing Imnovid registry.

This study will add to the registry. Indeed, pomalidomide-prescribing physicians and pharmacists dispensing pomalidomide have to enter into the Imnovid registry all patients who have been prescribed this drug since the date on which it was marketed regardless of the initiation date of pomalidomide or the indication for which it was prescribed.

Clinical Study Identifier: NCT02902900

Contact Investigators or Research Sites near you

Start Over

Associate Director Clinical Trial Disclosure

Clinique Du Parc
Castelnau Le Lez, France
1.0miles
  Connect »

Associate Director Clinical Trial Disclosure

Hopital Saint Eloi
Montpellier Cedex 5, France
2.36miles
  Connect »

Associate Director Clinical Trial Disclosure

Clinique Beau Soleil
Montpellier, France
3.44miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.